Literature DB >> 10811381

Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery.

A Décary1, I Rouleau, J Montplaisir.   

Abstract

Numerous studies have assessed a wide range of cognitive deficits associated with obstructive sleep apnea syndrome (OSAS). The comparison of these various results, however, is hampered by the fact that different studies employ different neuropsychological tests, even when assessing the same function. The aim of this paper is to present a standardized neuropsychological test battery for the evaluation of OSAS patients. Following a description of the general characteristics of OSAS, we review the main cognitive functions reported as being impaired in OSAS patients. These include general intellectual functioning, attentional functioning, memory and learning abilities, executive functions, and motor performance. Based on this review, we propose a test battery designed to cover these cognitive processes while taking into account the time constraints present in most research and clinical centers. In addition to providing a comprehensive neuropsychological evaluation of OSAS patients, the proposed test battery should facilitate the comparison of results from different laboratories.

Entities:  

Mesh:

Year:  2000        PMID: 10811381

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  57 in total

1.  An unusual case of neuro-Behçet's disease presenting with co-occurence of cerebral venous sinus thrombosis with basilar artery occlusion.

Authors:  Nida Fatma Tascilar; Gulsen Akman-Demir; Bekir Enes Demiryurek; Ozlem Tokgoz; Nergis Akgun; Banu Ozen Barut
Journal:  Neurol Sci       Date:  2012-06-04       Impact factor: 3.307

2.  The Oxford Sleep Resistance test (OSLER) and the Multiple Unprepared Reaction Time Test (MURT) detect vigilance modifications in sleep apnea patients.

Authors:  Anniina Alakuijala; Paula Maasilta; Adel Bachour
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

3.  Resting cerebral blood flow alteration in severe obstructive sleep apnoea: an arterial spin labelling perfusion fMRI study.

Authors:  Si Nie; De-Chang Peng; Hong-Han Gong; Hai-Jun Li; Li-Ting Chen; Cheng-Long Ye
Journal:  Sleep Breath       Date:  2017-02-16       Impact factor: 2.816

4.  Will APPLES hit a ceiling?

Authors:  Donald L Bliwise; Melanie C Greenaway
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

5.  The impact of moderate sleep loss on neurophysiologic signals during working-memory task performance.

Authors:  Michael E Smith; Linda K McEvoy; Alan Gevins
Journal:  Sleep       Date:  2002-11-01       Impact factor: 5.849

Review 6.  Decentralized cardiovascular autonomic control and cognitive deficits in persons with spinal cord injury.

Authors:  Jill M Wecht; William A Bauman
Journal:  J Spinal Cord Med       Date:  2013-03       Impact factor: 1.985

7.  White matter tract-specific alterations in male patients with untreated obstructive sleep apnea are associated with worse cognitive function.

Authors:  Dae Lim Koo; Hye Ryun Kim; Hosung Kim; Joon-Kyung Seong; Eun Yeon Joo
Journal:  Sleep       Date:  2020-03-12       Impact factor: 5.849

8.  Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age.

Authors:  Erik J Giltay; Aulikki Nissinen; Simona Giampaoli; Daan Kromhout
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-10       Impact factor: 2.959

9.  Relationship between sleep, sleep apnea, and neuropsychological function in children with Down syndrome.

Authors:  Lee J Brooks; Molly N Olsen; Ann Mary Bacevice; Andrea Beebe; Sofia Konstantinopoulou; H Gerry Taylor
Journal:  Sleep Breath       Date:  2014-05-07       Impact factor: 2.816

10.  Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia.

Authors:  Isabel C Burckhardt; David Gozal; Ehab Dayyat; Yu Cheng; Richard C Li; Aviv D Goldbart; Barry W Row
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.